Cargando…

Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma

Background: Circulating microRNAs (miRNAs) have proved to be promising biomarkers for early diagnosis and therapeutic monitoring in cancers. Particularly for hepatocellular carcinoma (HCC), detection of circulating miRNA biomarkers as a new diagnostic approach has been written into the latest Guidel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jun, Zhu, Xin-Chao, Wu, Xiao-Song, Wang, Lin, Zhu, Can-Can, Yang, Ke, Deng, Guo-Qing, Wang, An, Liu, Yong, Jia, Wei-Dong, Zhu, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592003/
https://www.ncbi.nlm.nih.gov/pubmed/33123293
http://dx.doi.org/10.7150/jca.48903
_version_ 1783601107291865088
author Zhao, Jun
Zhu, Xin-Chao
Wu, Xiao-Song
Wang, Lin
Zhu, Can-Can
Yang, Ke
Deng, Guo-Qing
Wang, An
Liu, Yong
Jia, Wei-Dong
Zhu, Ling
author_facet Zhao, Jun
Zhu, Xin-Chao
Wu, Xiao-Song
Wang, Lin
Zhu, Can-Can
Yang, Ke
Deng, Guo-Qing
Wang, An
Liu, Yong
Jia, Wei-Dong
Zhu, Ling
author_sort Zhao, Jun
collection PubMed
description Background: Circulating microRNAs (miRNAs) have proved to be promising biomarkers for early diagnosis and therapeutic monitoring in cancers. Particularly for hepatocellular carcinoma (HCC), detection of circulating miRNA biomarkers as a new diagnostic approach has been written into the latest Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2019 edition). However, no general consensus on an ideal endogenous normalizer for circulating miRNAs quantification has been reached, so it will affect the accuracy of quantitative results. In this study, we aim to identify a stable endogenous normalizer for analyzing circulating miRNAs. Methods: Candidate miRNAs were selected by screening dataset GSE104310, as well as data statistics and analysis. Five commonly reference genes were chosen for further comparison and verification. Then, the expression levels of these genes in serum were analyzed by quantitative reverse transcription PCR (RT-qPCR) among four groups, including patients diagnosed with HCC, chronic hepatitis B (CHB), liver cirrhosis, and healthy subjects. Furthermore, the stability of target genes was evaluated using geNorm, NormFinder, comparative ΔCq programs, and validated by database. We also explored the availability of the miRNA combination, and compared the performance difference between combination and individuals, as well as the selectivity of miRNA references in the combinations. Results: 11 candidate miRNAs were obtained, and miR-4644 stood out among these miRNAs, and proved to be much more stable than other endogenous miRNAs. Further study showed that miR-4644 exhibited higher stability and expression abundance than other commonly miRNA reference controls. Finally, we discovered the combination of miR-4644 and miR-16 revealed high performance in stability when compared to miRNA individuals. Furthermore, the combination consisted of references with closer nature could give rise to amplification effects in stability. Conclusions: Our findings demonstrated that miR-4644 is an ideal endogenous normalizer for circulating microRNA quantification in hepatocellular carcinoma. Besides, combining miR-4644 with miR-16 into a whole as a reference control would greatly improve the accuracy of quantification.
format Online
Article
Text
id pubmed-7592003
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-75920032020-10-28 Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma Zhao, Jun Zhu, Xin-Chao Wu, Xiao-Song Wang, Lin Zhu, Can-Can Yang, Ke Deng, Guo-Qing Wang, An Liu, Yong Jia, Wei-Dong Zhu, Ling J Cancer Research Paper Background: Circulating microRNAs (miRNAs) have proved to be promising biomarkers for early diagnosis and therapeutic monitoring in cancers. Particularly for hepatocellular carcinoma (HCC), detection of circulating miRNA biomarkers as a new diagnostic approach has been written into the latest Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2019 edition). However, no general consensus on an ideal endogenous normalizer for circulating miRNAs quantification has been reached, so it will affect the accuracy of quantitative results. In this study, we aim to identify a stable endogenous normalizer for analyzing circulating miRNAs. Methods: Candidate miRNAs were selected by screening dataset GSE104310, as well as data statistics and analysis. Five commonly reference genes were chosen for further comparison and verification. Then, the expression levels of these genes in serum were analyzed by quantitative reverse transcription PCR (RT-qPCR) among four groups, including patients diagnosed with HCC, chronic hepatitis B (CHB), liver cirrhosis, and healthy subjects. Furthermore, the stability of target genes was evaluated using geNorm, NormFinder, comparative ΔCq programs, and validated by database. We also explored the availability of the miRNA combination, and compared the performance difference between combination and individuals, as well as the selectivity of miRNA references in the combinations. Results: 11 candidate miRNAs were obtained, and miR-4644 stood out among these miRNAs, and proved to be much more stable than other endogenous miRNAs. Further study showed that miR-4644 exhibited higher stability and expression abundance than other commonly miRNA reference controls. Finally, we discovered the combination of miR-4644 and miR-16 revealed high performance in stability when compared to miRNA individuals. Furthermore, the combination consisted of references with closer nature could give rise to amplification effects in stability. Conclusions: Our findings demonstrated that miR-4644 is an ideal endogenous normalizer for circulating microRNA quantification in hepatocellular carcinoma. Besides, combining miR-4644 with miR-16 into a whole as a reference control would greatly improve the accuracy of quantification. Ivyspring International Publisher 2020-10-17 /pmc/articles/PMC7592003/ /pubmed/33123293 http://dx.doi.org/10.7150/jca.48903 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Zhao, Jun
Zhu, Xin-Chao
Wu, Xiao-Song
Wang, Lin
Zhu, Can-Can
Yang, Ke
Deng, Guo-Qing
Wang, An
Liu, Yong
Jia, Wei-Dong
Zhu, Ling
Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma
title Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma
title_full Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma
title_fullStr Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma
title_full_unstemmed Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma
title_short Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma
title_sort identification of mir-4644 as a suitable endogenous normalizer for circulating mirna quantification in hepatocellular carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592003/
https://www.ncbi.nlm.nih.gov/pubmed/33123293
http://dx.doi.org/10.7150/jca.48903
work_keys_str_mv AT zhaojun identificationofmir4644asasuitableendogenousnormalizerforcirculatingmirnaquantificationinhepatocellularcarcinoma
AT zhuxinchao identificationofmir4644asasuitableendogenousnormalizerforcirculatingmirnaquantificationinhepatocellularcarcinoma
AT wuxiaosong identificationofmir4644asasuitableendogenousnormalizerforcirculatingmirnaquantificationinhepatocellularcarcinoma
AT wanglin identificationofmir4644asasuitableendogenousnormalizerforcirculatingmirnaquantificationinhepatocellularcarcinoma
AT zhucancan identificationofmir4644asasuitableendogenousnormalizerforcirculatingmirnaquantificationinhepatocellularcarcinoma
AT yangke identificationofmir4644asasuitableendogenousnormalizerforcirculatingmirnaquantificationinhepatocellularcarcinoma
AT dengguoqing identificationofmir4644asasuitableendogenousnormalizerforcirculatingmirnaquantificationinhepatocellularcarcinoma
AT wangan identificationofmir4644asasuitableendogenousnormalizerforcirculatingmirnaquantificationinhepatocellularcarcinoma
AT liuyong identificationofmir4644asasuitableendogenousnormalizerforcirculatingmirnaquantificationinhepatocellularcarcinoma
AT jiaweidong identificationofmir4644asasuitableendogenousnormalizerforcirculatingmirnaquantificationinhepatocellularcarcinoma
AT zhuling identificationofmir4644asasuitableendogenousnormalizerforcirculatingmirnaquantificationinhepatocellularcarcinoma